Elias Campo Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

12/2021	SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.
1/2021	A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma.
1/2020	Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma.
11/2019	Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
1/2019	CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.
1/2018	Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.
1/2018	SOX11, a key oncogenic factor in mantle cell lymphoma.
11/2017	The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status.
5/2017	New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.
1/2017	Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elias Campo Research Topics

Disease

78	Neoplasms (Cancer) 01/2022 - 01/2002
40	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 01/2002
34	Lymphoma (Lymphomas) 01/2021 - 03/2002
29	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 06/2002
24	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 09/2002
12	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 06/2004
11	Disease Progression 01/2021 - 11/2004
7	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2016 - 06/2006
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 11/2006
6	Leukemia 01/2018 - 06/2004
6	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2014 - 04/2002
4	Trisomy (Trisomies) 12/2021 - 01/2018
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 02/2014
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2019 - 02/2002
4	Genetic Translocation (Chromosomal Translocation) 03/2008 - 01/2005
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 02/2013
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 06/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017 - 10/2010
3	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2011 - 01/2002
3	Chromosomal Instability (Chromosome Stability) 10/2008 - 12/2002
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2020
2	Multiple Myeloma 01/2021 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 01/2016
2	Carcinoma (Carcinomatosis) 11/2006 - 11/2005
1	Uveitis 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease) 12/2019

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
19	Biological ProductsIBA 01/2022 - 11/2006
13	Cyclin D1IBA 01/2021 - 02/2003
12	Rituximab (Mabthera)FDA Link 10/2018 - 01/2011
10	Messenger RNA (mRNA)IBA 01/2017 - 12/2002
9	Phosphotransferases (Kinase)IBA 12/2021 - 01/2002
9	CyclinsIBA 01/2021 - 12/2005
9	ParaffinIBA 01/2018 - 10/2008
8	Pharmaceutical PreparationsIBA 12/2021 - 09/2002
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
7	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 03/2002
7	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 06/2002
6	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2008
6	Formaldehyde (Formol)FDA Link 01/2018 - 06/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017 - 09/2002
6	Anaplastic Lymphoma KinaseIBA 05/2014 - 04/2002
5	ChromatinIBA 01/2021 - 01/2017
5	AntigensIBA 01/2019 - 02/2002
5	fludarabineIBA 04/2017 - 09/2002
5	Bortezomib (Velcade)FDA Link 02/2013 - 01/2006
4	AntibodiesIBA 01/2014 - 03/2002
4	Prednisone (Sone)FDA LinkGeneric 10/2012 - 11/2011
4	Vincristine (Oncovin)FDA LinkGeneric 10/2012 - 11/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012 - 11/2011
4	Cyclin D2IBA 11/2009 - 02/2004
4	Pyridinolcarbamate (P23)IBA 01/2005 - 04/2002
3	ibrutinibIBA 12/2020 - 09/2015
3	LigandsIBA 12/2019 - 11/2004
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 09/2004
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 10/2010
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 06/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 09/2002
3	NucleosidesIBA 08/2015 - 07/2006
3	Cytidine DeaminaseIBA 06/2015 - 07/2006
3	RNA (Ribonucleic Acid)IBA 02/2014 - 08/2010
3	Proteasome InhibitorsIBA 11/2011 - 01/2006
3	Immunoglobulin M (IgM)IBA 01/2010 - 03/2002
3	NF-kappa B (NF-kB)IBA 04/2009 - 06/2006
3	NucleophosminIBA 01/2005 - 08/2004
2	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 11/2017
2	ChemokinesIBA 12/2021 - 01/2018
2	CytokinesIBA 12/2021 - 01/2019
2	venetoclaxIBA 12/2020 - 08/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 06/2013
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020 - 01/2019
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019 - 02/2011
2	Chemokine ReceptorsIBA 01/2019 - 01/2017
2	ElementsIBA 01/2018 - 03/2013
2	Chlorambucil (Leukeran)FDA Link 06/2017 - 02/2013
2	carboxyl radical (COO-)IBA 02/2014 - 06/2011
2	Monoclonal AntibodiesIBA 01/2014 - 08/2011
2	Bendamustine Hydrochloride FDA Link 11/2013 - 11/2008
2	SOXC Transcription FactorsIBA 03/2013 - 11/2009
2	Endoplasmic Reticulum Chaperone BiPIBA 11/2011 - 01/2011
2	Tyrosine (L-Tyrosine)FDA Link 12/2010 - 08/2004
2	I-kappa B KinaseIBA 04/2009 - 02/2007
2	Adenosine Monophosphate (AMP)IBA 10/2008 - 06/2006
2	Antigen Receptors (Antigen Receptor)IBA 03/2008 - 07/2006
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2006 - 03/2003
2	Complementary DNA (cDNA)IBA 09/2005 - 01/2004
1	InterferonsIBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2021
1	STAT2 Transcription FactorIBA 12/2021
1	CD40 Ligand (CD40L)IBA 12/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020
1	delta proteinIBA 11/2019

Therapy/Procedure

27	Therapeutics 12/2021 - 02/2003
10	Drug Therapy (Chemotherapy) 01/2019 - 06/2002
2	Stem Cell Transplantation 06/2006 - 02/2002
1	Vitrectomy 01/2022
1	Precision Medicine 01/2022
1	Breast Implants (Breast Implant) 12/2019